Transcriptomics

Dataset Information

0

Nicotinamide mononucleotide, a key NAD+ precursor, treats the pathophysiology of diet- and age-induced diabetes


ABSTRACT: Type 2 diabetes (T2D) has become an epidemic in our modern lifestyle, likely due to calorie-rich diets overwhelming our adaptive metabolic pathways. One such pathway is mediated by nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme in mammalian NAD+ biosynthesis, and the NAD+-dependent protein deacetylase SIRT1. Here we show that NAMPT-mediated NAD+ biosynthesis is severely compromised in metabolic organs by high-fat diet (HFD). Strikingly, nicotinamide mononucleotide (NMN), a product of the NAMPT reaction and a key NAD+ intermediate, ameliorates glucose intolerance by restoring NAD+ levels in HFD-induced T2D mice. NMN also enhances hepatic insulin sensitivity and restores gene expression related to oxidative stress, inflammatory response, and circadian rhythm, partly through SIRT1 activation. Furthermore, NAD+ and NAMPT levels show significant decreases in multiple organs during aging, and NMN improves glucose intolerance and lipid profiles in age-induced T2D mice. These findings provide critical insights into a novel intervention against diet- and age-induced T2D.

ORGANISM(S): Mus musculus

PROVIDER: GSE31647 | GEO | 2011/12/05

SECONDARY ACCESSION(S): PRJNA145417

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2011-12-05 | E-GEOD-31647 | biostudies-arrayexpress
2009-05-28 | GSE13577 | GEO
2014-05-08 | E-GEOD-49784 | biostudies-arrayexpress
2014-05-08 | GSE49784 | GEO
2016-12-01 | GSE85718 | GEO
2024-08-09 | PXD033027 | Pride
2023-06-03 | GSE233644 | GEO
2019-01-01 | GSE118365 | GEO
2021-07-28 | GSE171565 | GEO
2023-04-11 | GSE221550 | GEO